Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.

Autor: Goodwin GM; COMPASS Pathfinder Ltd, London, UK. Electronic address: guy.goodwin@compasspathways.com., Aaronson ST; The Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt, Baltimore, MD, USA; Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA., Alvarez O; Parc Sanitari Sant Joan de Déu, Barcelona, Spain; Sant Joan de Déu Research Foundation, Barcelona, Spain., Atli M; COMPASS Pathfinder Ltd, London, UK., Bennett JC; COMPASS Pathfinder Ltd, London, UK., Croal M; COMPASS Pathfinder Ltd, London, UK., DeBattista C; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA., Dunlop BW; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA., Feifel D; Kadima Neuropsychiatric Institute, La Jolla, CA, USA., Hellerstein DJ; New York State Psychiatric Institute, New York, NY, USA; Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA., Husain MI; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada., Kelly JR; Department of Psychiatry, Trinity Centre for Health Sciences, Tallaght University Hospital, Dublin, Ireland., Lennard-Jones MR; COMPASS Pathfinder Ltd, London, UK., Licht RW; Department of Psychiatry, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Marwood L; COMPASS Pathfinder Ltd, London, UK., Mistry S; COMPASS Pathfinder Ltd, London, UK., Páleníček T; The National Institute of Mental Health, Klecany, Czech Republic., Redjep O; COMPASS Pathfinder Ltd, London, UK., Repantis D; Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany., Schoevers RA; Department of Psychiatry, University Medical Centre Groningen, Groningen, the Netherlands., Septimus B; COMPASS Pathfinder Ltd, London, UK., Simmons HJ; COMPASS Pathfinder Ltd, London, UK., Soares JC; UTHealth Harris County Psychiatric Center, Houston, TX, USA; Department of Psychiatry and Behavioral Sciences, UTHealth Center of Excellence on Mood Disorders, UT Houston Medical School, Houston, TX, USA., Somers M; Department of Psychiatry, University Medical Centre Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands., Stansfield SC; COMPASS Pathfinder Ltd, London, UK., Stuart JR; COMPASS Pathfinder Ltd, London, UK., Tadley HH; COMPASS Pathfinder Ltd, London, UK., Thiara NK; COMPASS Pathfinder Ltd, London, UK., Tsai J; COMPASS Pathfinder Ltd, London, UK., Wahba M; Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, UK; Newcastle University, Newcastle upon Tyne, UK., Williams S; COMPASS Pathfinder Ltd, London, UK., Winzer RI; COMPASS Pathfinder Ltd, London, UK., Young AH; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, London, UK., Young MB; COMPASS Pathfinder Ltd, London, UK., Zisook S; Department of Psychiatry, University of California San Diego, San Diego, CA, USA., Malievskaia E; COMPASS Pathfinder Ltd, London, UK.

Publikováno v: Journal of affective disorders [J Affect Disord] 2023 Apr 14; Vol. 327, pp. 120-127. Date of Electronic Publication: 2023 Feb 04.